InsidersTradesSigma
Bal Pharma Limited: directors' dealings · India · SEBI (PIT + SAST)
SEBI:bal-pharma-limitedIN·SEBI (PIT + SAST)Mcap 1.3Bn€
Explore the full directors' dealings record of Bal Pharma Limited, a listed issuer based in India. Shares are listed on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €1.3bn. The latest transaction was reported on 13 April 2022 (Purchase). Among the most active insiders: MICRO LABS LIMITED. Every trade is openly available.
3
Insider Decl.
0
Thresholds
€896,641
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
76.88 €
Income statement
Revenue3.03 Bn€
Gross profit1.33 Bn€44% margin
Net income72.2 M€2.4% margin
Balance sheet & cash
Market cap1.32 Bn€
Total debt1.50 Bn€
Free Cash Flow15.3 M€
Last declaration on 13 April 2022
Declarations3 total
Executives●Purchase0SEBI
€451,650750,000 shares@ €0.6022
Equity Shares
SEBI:620ffbe1381314cef64b742e0cfc96a4e6493462·
Ideal exit: 8 Jan 2023 (T+270)
Executives●Purchase0SEBI
€441,542400,000 shares@ €1.1039
Equity Shares
SEBI:5227c13838f4f22691e2aeda69eb2fe3b83d77c9·
Ideal exit: 20 Aug 2022 (T+270)
Executives●Purchase10SEBI
€3,449300,900 shares@ €0.01150.0003% mcap100.0% of flow
Equity Shares
SEBI:c65f6d34ee8d0fd3c0b875aeb0b3601839bc075d·
Ideal exit: 24 May 2022 (T+270)
3 of 3 declarations